Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

A Registry Study on HIV-related Lymphoma

NCT05231135

Conditions: AIDS Related Lymphoma, HIV Related Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Red Cross Hospital Munich Munich, Select One Option, Germany

University Hospital Cologne Cologne, Germany

Amsterdam University Medical Centers Amsterdam, Netherlands

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View Trial Details

Recruiting

A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma

NCT05521802

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institute of Hematology and Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

NCT05648019

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR, +28 more
Locations: Singapore General Hospital Singapore

KK Women's and Children's Hospital Singapore

View Trial Details

Recruiting

Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia

NCT05210907

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol

NCT05682131

Conditions: Arsenic Trioxide, Childhood ALL, Hematologic Diseases, +10 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL

NCT05659628

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital Hangzhou, Zhejiang, China

Ningbo First Hospital Ningbo, Zhejiang, China

View Trial Details

Recruiting

Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM

NCT05594797

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

The First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China

View Trial Details

Recruiting

Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

NCT05626400

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Hebei yanda Hospital Beijingcun, Hebei, China

View Trial Details

Recruiting

CD7 CAR-T Cells in T-cell Lymphoma/Leukemia

NCT05620680

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Li Yu Shenzhen, Guangdong, China

View Trial Details

Recruiting

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NCT04922567

Conditions: CHOP, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions